Medexus Pharmaceuticals Inc, MEDXF:QXE profile

Price (USD)1.39
Today's Change-0.08 / -5.46%
Shares traded14.23k
1 Year change+2.97%
Beta--

Data delayed at least 15 minutes, as of Nov 12 2024 21:52 GMT.

More ▼

Add to Your Portfolio

Name

Currency

Profile data is unavailable for this security.

About the company

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Revenue in CAD (TTM)145.87m
Net income in CAD3.20m
Incorporated2021
Employees98.00

Location
Medexus Pharmaceuticals Inc10 King Street East, Suite 600TORONTO M5C 1C3CanadaCAN
Phone+1 (514) 762-2626
Websitehttps://www.medexus.com/en_US

More ▼

Income statement (USD)

Year on year Medexus Pharmaceuticals Inc had net income fall from a gain of 1.22m to a loss of 214.00k despite a 4.59% increase in revenues from 108.10m to 113.05m. An increase in the cost of goods sold as a percentage of sales from 44.46% to 47.36% was a component in the falling net income despite rising revenues.

Explore our tools

Growth CalculatorBETA
Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes
Alerts
Create detailed alerts and get notified the moment an event happens
Watchlists
Monitor a select list of assets
Are you sure you want to cancel?
Portfolio
See how trades would have performed from years past or start from the present
Data archive
Download PDF copies of reports from the newspaper markets data page
World markets
View the performance of global markets and browse news items by region
Equities screener
Find companies based on country, sector, and other equity characteristics
Funds overview
View funds that move the market, screen for funds and read relevant news

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Medexus Pharmaceuticals Inc

Select symbol

Medexus Pharmaceuticals Inc

ApplyActions

Your alerts

About the company